Thursday's analyst calls feature upgrades to discount retailers TJX and Burlington and used car outlet Carvana, while there was more bad news for CVS Health following a tough earnings report Wednesday. He also raised his price target to $130 from $70, or 49.2% above Wednesday's close price. He lowered his price target by $25 to $60, or just 5.6% higher from Wednesday's close price. Analyst Jay Sole also lifted his price target to $132 from $104, indicating nearly 41% upside from Wednesday's close. He raised his price target to $212 from $126, suggesting shares could gain 19.1% from where they closed Wednesday.

---

Persons: Morgan Stanley, Joseph Moore, Moore, Samik Chatterjee, Chatterjee, Tal Liani, Liani, — Hakyung Kim, JPMorgan Carvana, Rajat Gupta, Gupta, Kevin Caliendo, Caliendo, Jay Sole, Sole, BURL, — Hakyung Kim —, Michael Bloom Organizations: CNBC, CVS Health, UBS, CVS, JPMorgan, Qualcomm, Wall Street, Samsung, Huawei, Edge, headwinds, " Bank of America, Microsoft, Burlington Discount, TJX Companies, Burlington Stores, Burlington Locations: Burlington, Carvana, CY24, seasonality, optionality, Maxx